Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

Joanna M. Wardlaw(UK Dementia Research Institute), Geoff Cohen(University of Edinburgh), Eivind Berge(Oslo University Hospital), Gregory del Zoppo(University of Washington), Richard I. Lindley(Westmead Hospital), Veronica Murray(Karolinska Institutet), Peter Sandercock(University of Edinburgh)
The Lancet
May 23, 2012
10.1016/s0140-6736(12)60738-7
Cited by 1,006

Related Papers

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
|The Lancet|2014|2.7k
Interpretation of the evidence for the efficacy and safety of statin therapy
|The Lancet|2016|1.8k
Small vessel disease: mechanisms and clinical implications
|The Lancet Neurology|2019|1.7k
Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke
|Stroke|2013|1.7k